Pharmaceutical Analysis & Statistics, February 2015

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

  • All
    • Global Data

All regions

1-30 of about 6 300 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - 5EU Drug ...

  • Industries : Pathology
  • Countries : Germany, Spain, Italy, France, United Kingdom, Europe, World
PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - US Drug ...

  • Industries : Pathology
  • Countries : United States
PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - Japan ...

  • Industries : Pathology
  • Countries : Japan
PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - China ...

  • Industries : Pathology
  • Countries : China
EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023 Summary Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China
EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks ...

  • Industries : Pathology
  • Countries : Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe
EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023 Summary Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, ...

  • Industries : Pathology
  • Countries : World, United States
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • November 2014
  • by Global Data

EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023 Summary Celiac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • November 2014
  • by Global Data

EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune ...

  • Industries : Pathology
  • Countries : Canada, Japan, World, United States, Spain, Italy, France, Germany
Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Avastin (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Erbitux (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Erbitux (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Vectibix (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Vectibix (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, United States, United Kingdom, Europe
Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Stivarga (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Stivarga (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, Europe, United States, United Kingdom
Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Zaltrap (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zaltrap (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, China, Europe, United States, United Kingdom
TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

TS-1 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TS-1 (Colorectal Cancer) - Forecast and Market Analysis to ...

  • Industries : Pathology
  • Countries : Japan
Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Lonsurf (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lonsurf (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, China, Europe, United States, United Kingdom
Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Cyramza (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Imprime PGG (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Imprime PGG (Colorectal Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

MGN1703 (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “MGN1703 (Colorectal Cancer) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Europe, United Kingdom
Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Company report
  • November 2014
  • by Global Data

Nintedanib (Colorectal Cancer) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Nintedanib (Colorectal Cancer) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, Europe, United States, United Kingdom
PharmaPoint: Colorectal Cancer - Current and Future Players

PharmaPoint: Colorectal Cancer - Current and Future Players

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Colorectal Cancer - Current and Future Players”. The report is a vital source ...

  • Industries : Pathology
  • Countries : World
Pancreatitis Global Clinical Trials Review, H2, 2014

Pancreatitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Pancreatitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pancreatitis Global Clinical Trials Review, H2, 2014" provides data on the Pancreatitis clinical trial ...

  • Industries : Drug Discovery and Development
  • Countries : World
Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides ...

  • Industries : Pathology
  • Countries : World, United States
Mycoses Global Clinical Trials Review, H2, 2014

Mycoses Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Mycoses Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Mycoses Global Clinical Trials Review, H2, 2014" provides data on the Mycoses clinical trial scenario. This ...

  • Industries : Drug Discovery and Development
  • Countries : World
Nosocomial Infections Global Clinical Trials Review, H2, 2014

Nosocomial Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Nosocomial Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Nosocomial Infections Global Clinical Trials Review, H2, 2014" provides data on the Nosocomial ...

  • Industries : Drug Discovery and Development
  • Countries : World
Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014

Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014" provides data on ...

  • Industries : Drug Discovery and Development
  • Countries : World
Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2014

Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2014" provides ...

  • Industries : Drug Discovery and Development
  • Countries : World
Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014

Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pneumococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Pneumococcal ...

  • Industries : Drug Discovery and Development
  • Countries : World
Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014

Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Pneumocystis Carinii Pneumonia Global Clinical Trials Review, H2, 2014" provides data ...

  • Industries : Drug Discovery and Development
  • Countries : World
Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2014

Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Oropharyngeal Candidiasis Global Clinical Trials Review, H2, 2014" provides data on the ...

  • Industries : Drug Discovery and Development
  • Countries : World

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.